Exchange: NASDAQ·Updated 07:30 PM EST
ZBIO logo

ZBIO Zenas Biopharma Inc.

$23.00
$1.19
(4.75%)
Today
Closed $23.85
$0.85
(3.56%)
After Hours
Reported EarningsNov 5
Mkt Cap$1.62B
Vol579,897.00

About ZBIO

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
42

Bearish Sentiment

How do you feel about ZBIO?

Quantumup
Citi added $ZBIO (Buy-$48) to its Upside 90-Day Catalyst Watch List—believes the SunStone readout in systemic lupus erythematosus (SLE) in Q4 is well positioned to hit the primary endpoint.
1
chole1
$ZBIO can we finally get that "stupid" SLE update behind so that we can move on, and up again?
chole1
$ZBIO Novartis calling its BTKinhibitor probably biggest ever drug... where will ZBIO trade if its own BTKinh reports positive P3 results? Lets see if safety holds up, that would be massive

Advertisement|Remove ads.